The Remimazolam Market is positioned for significant expansion as healthcare systems increasingly demand safe, efficient, and controllable anesthetic agents. WiseGuyReports forecasts growth from USD 500 million in 2025 to USD 1.5 billion by 2035, representing a CAGR of 10.6%. Increasing surgical and diagnostic procedures are among the primary factors supporting market growth. The expanding...